相关实验视频
Updated: May 3, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.1K
在急性ST升高心肌梗塞的患者中,丁氏甲基与丁氏甲基对比:回顾性队列研究
Adham Mohamed1, Sara Mahmoud2, Amr M Fahmi3
1Department of Pharmacy, Saint Luke's Hospital of Kansas City, Kansas City, MO, USA.
概括
丁氏甲和丁氏甲在急性心肌梗塞中表现出类似的疗效,但丁氏甲的重大出血率明显较低. 建议进行进一步的随机试验,以证实对STEMI患者血栓溶解的这些发现.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性ST升高心肌梗塞 (STEMI) 需要快速的再输血治疗.
- 纤维溶解剂,如丁氏甲和丁氏甲,用于恢复血液流动.
- 对比这些药物的实际有效性和安全性对于临床决策至关重要.
研究的目的:
- 在患有急性STEMI的患者中,比较tenecteplase与reteplase的疗效和安全性.
- 为了评估失败的血栓溶解,严重出血,心脏性休克,复发性心脏病发作和死亡率的差异.
主要方法:
- 一个多中心的回顾性观察性研究.
- 包括282名患有急性STEMI的患者,他们接受了基 (n=229) 或基 (n=53) 的治疗.
- 主要结局:失败的血栓溶解. 二次结局:严重出血,心脏性休克,复发性心脏病发作和死亡率.
主要成果:
- 失败的血栓溶解发生在33.2%的丁氏甲基酶组,而在丁氏甲基酶组为20.8% (p=0.089).
- 与 reteplase (5.7%) (p=0.017) 相比,使用 tenecteplase (0.9%) 的重大出血事件显著减少.
- 两组之间没有观察到死亡率或其他次要结果的显著差异.
结论:
- 甲和甲在急性STEMI中对失败的血栓溶解表现出可比的疗效.
- 甲与严重出血事件的发生率显著降低有关.
- 随机对照试验是有必要的,以验证这些发现,并指导最佳的纤维素分析疗法选择.
相关概念视频
01:18Effects of EDTA on End-Point Detection Methods
819
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
819
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
01:28Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749